About HAYA Therapeutics
At HAYA Therapeutics, we are revolutionizing RNA-guided genome-targeting therapies to treat fibrosis, heart failure, and other serious chronic diseases associated with aging. Our innovative platform leverages long non-coding RNAs (lncRNAs) - key regulators within the “dark matter” of the genome - to develop first-in-class, highly specific therapies that reprogram disease-driving cell states into a healthy and resilient state, tackling disease at its roots.
Following the successful close of our Series A financing, HAYA is well-positioned to advance our pipeline and execute on key scientific and operational milestones, including the advancement of HAYA’s lead program, HTX-001, toward the clinic for the treatment of non-obstructive hypertrophic cardiomyopathy (nHCM).
In recognition of our scientific innovation and potential global impact, we have been named one of the 100 early-stage companies selected for the World Economic Forum’s 2025 Technology Pioneers.
As a fast-growing biotech, we offer an entrepreneurial, science-driven environment where you’ll have a direct impact on shaping our programs and advancing the future of RNA medicine.
Position Summary
HAYA Therapeutics is seeking a highly experienced, senior-level data science leader to take a prominent and highly visible role within the Data Science team. This position exists to ensure that complex preclinical and translational datasets are transformed into high-quality, decision-ready scientific outputs that support program advancement, platform positioning, and external engagement.
In this strategic role, you will act as a scientific gatekeeper for data and materials generated in the cardiac and cardiorenal space, ensuring rigor, consistency, and scientific credibility across multiple therapeutic programs.
You will serve as a senior scientific authority at the interface of computational biology and cardiac disease biology. Acting as a bridge between data science and biology, you will apply deep domain knowledge and multi-omics expertise to interpret complex datasets, guide analytical strategy, and ensure biological accuracy and translational relevance.
This role requires strong judgment, autonomy, and the ability to set analytical standards, particularly for cardiac-focused preclinical and translational research, while partnering closely with biology, translational, and clinical stakeholders.
A core component of this role is creating and owning high-impact scientific content and narratives for board-level discussions, alliance management, and business development. You will take complex, multi-layered scientific analyses and translate them into clear, compelling stories that explain the “why,” “so what,” and strategic implications behind the data.
This role requires the ability to frame scientific results within a broader platform and program context, connecting individual analyses into coherent narratives that articulate the value, differentiation, and trajectory of HAYA’s science. You will ensure that all scientific storytelling is accurate, rigorous, and aligned with the company’s strategic objectives.
You will play a highly visible role in representing HAYA’s scientific capabilities to internal leadership and external partners, tailoring scientific stories for senior technical and non-technical audiences while maintaining the highest standards of scientific integrity.
What’s in it for me?
This role offers a rare opportunity to operate at the intersection of science and business, serving as a bridge between complex biological data and strategic decision-making. You will not only analyze and interpret science, but also shape how HAYA’s platform, programs, and data are translated into clear narratives that inform leadership, partners, and investors.
Your work will directly influence program direction, business development opportunities, and how the company’s scientific value is communicated externally. This is a highly visible role with meaningful exposure across the organization and to external stakeholders, set within a collaborative and innovative culture that values scientific curiosity, sound judgment, and ownership, and supports your continued growth as a senior scientific leader.
Key Responsibilities
Scientific Leadership & Platform Showcasing
Computational Biology
Cross-Functional Collaboration
Education & Experience
HAYA Therapeutics is a precision medicines company developing RNA-guided programmable therapeutics targeting the regulatory genome for serious health conditions including cardiovascular disease and cancer. The company is using its innovative cell-state modifying platform to gain novel insights into the biology of long non-coding RNAs (lncRNAs), the ‘dark genomes’ information processing features and ‘source code’. HAYA’s lead therapeutic candidate is HTX-001, an antisense oligonucleotide targeting Wisper, which is a tissue and cell-specific cardiac lncRNA known to play a role in heart failure. The company is also developing a pipeline of lncRNA-targeting candidates for the cell-specific treatment of diseases in other tissues, including the lungs and the microenvironment of solid tumor cancers. Headquartered at the life sciences park Biopôle in Lausanne, Switzerland with laboratory facilities at Lilly Gateway Labs, powered by Alexandria, in San Diego, HAYA is led by a world-class team of experts in programmable and precision RNA-targeted therapeutics and is supported by a strong investor consortium. HAYA’s mission is to identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility than existing treatments.